Company Overview

Update
Headquarters:
Jerusalem
Funding:
$1.50M
Categories:
Biotechnology

One of the major advances in cancer research over the past decade has been the realization that tumor growth is dependent on the tumor's

Description

Update

One of the major advances in cancer research over the past decade has been the realization that tumor growth is dependent on the tumor's ability to recruit blood vessels from the neighboring tissue. Angiogenesis, the process by which new blood vessels are formed, is a hallmark capability of cancer, critical for the development of all solid tumors. This property is the basis for anti-angiogenic therapy, a promising novel strategy for treatment of cancer.

Current Team (2)

Update

Funding Rounds (1) - $1.50M

Update
  • $1.50M

    Investors Unknown
    Feb 5, 2014 -Unknown

Offices/Locations (1)

Update
  • Office

    1-1 Hi-tech Village, Edmond Safra Campus Givat Ram

    P.O.B. 39026,

    Jerusalem, 91390

    ISR

Images (1)

Update
  • A3b30658199cb15e234a9178494d3e32